Skip to content
10-Q

Quarterly Report

Neurotrope, Inc.

0001104659-20-092817

← back to feed
Filed
Aug 10, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 5, 2020 23.78M sh
Capex Q2 2020 · Jun 30, 2020 $5.41K
Capex Q2 2020 · Jun 30, 2019 $5.21K
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$3.65M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$7.64M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $30.25M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $17.38M
Stockholders Equity Q2 2020 · Jun 30, 2020 $29.8M
Stockholders Equity Q2 2020 · Mar 31, 2020 $32.18M
Stockholders Equity Q2 2020 · Dec 31, 2019 $17.42M
Stockholders Equity Q2 2020 · Mar 31, 2019 $23.43M
Stockholders Equity Q2 2020 · Dec 31, 2018 $26.52M
Current Liabilities Q2 2020 · Jun 30, 2020 $1.07M
Current Liabilities Q2 2020 · Dec 31, 2019 $479.06K
Current Assets Q2 2020 · Jun 30, 2020 $30.84M
Current Assets Q2 2020 · Dec 31, 2019 $17.88M
Total Assets Q2 2020 · Jun 30, 2020 $30.87M
Total Assets Q2 2020 · Dec 31, 2019 $17.9M
Sga Expense Q2 2020 · Jun 30, 2020 $2.17M
Sga Expense Q2 2020 · Jun 30, 2020 $3.95M
Sga Expense Q2 2020 · Jun 30, 2019 $1.71M
Sga Expense Q2 2020 · Jun 30, 2019 $3.03M
Rd Expense Q2 2020 · Jun 30, 2020 $438.42K
Rd Expense Q2 2020 · Jun 30, 2020 $594.47K
Rd Expense Q2 2020 · Jun 30, 2019 $1.57M
Rd Expense Q2 2020 · Jun 30, 2019 $3.43M
Net Income Q2 2020 · Jun 30, 2020 −$2.93M
Net Income Q2 2020 · Jun 30, 2020 −$5.47M
Net Income Q2 2020 · Jun 30, 2019 −$4.01M
Net Income Q2 2020 · Jun 30, 2019 −$8.7M